Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Corbus Pharmaceuticals Hldgs Inc (CRBP)

Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 543,968
  • Shares Outstanding, K 10,687
  • Annual Sales, $ 0 K
  • Annual Income, $ -44,600 K
  • 60-Month Beta 2.56
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.75
Trade CRBP with:

Options Overview Details

View History
  • Implied Volatility 224.32% ( +48.32%)
  • Historical Volatility 87.58%
  • IV Percentile 99%
  • IV Rank 100.00%
  • IV High 224.32% on 09/18/24
  • IV Low 80.43% on 07/19/24
  • Put/Call Vol Ratio 0.29
  • Today's Volume 1,575
  • Volume Avg (30-Day) 655
  • Put/Call OI Ratio 1.03
  • Today's Open Interest 17,048
  • Open Int (30-Day) 11,689

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.99
  • Number of Estimates 6
  • High Estimate -0.78
  • Low Estimate -1.14
  • Prior Year -2.27
  • Growth Rate Est. (year over year) +56.39%

Price Performance

See More
Period Period Low Period High Performance
1-Month
47.95 +3.44%
on 09/18/24
61.89 -19.86%
on 08/22/24
-3.92 (-7.32%)
since 08/16/24
3-Month
41.71 +18.92%
on 06/24/24
61.90 -19.87%
on 07/31/24
+5.79 (+13.22%)
since 06/18/24
52-Week
3.03 +1,535.13%
on 11/13/23
61.90 -19.87%
on 07/31/24
+42.50 (+598.59%)
since 09/18/23

Most Recent Stories

More News
Corbus Pharmaceuticals: Q2 Earnings Snapshot

Corbus Pharmaceuticals: Q2 Earnings Snapshot

CRBP : 49.63 (-2.50%)
Up Over 700% YTD, Here's How Much Higher Analysts Think This Biotech Stock Can Rise

As the biotech industry rebounds from recent challenges, a favorable regulatory environment and groundbreaking scientific advancements are creating investment opportunities, particularly in companies with...

CRBP : 49.63 (-2.50%)
Stocks Climb on Lower Bond Yields and Positive Corporate News

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.11%. US stocks this morning...

$SPX : 5,657.37 (+0.40%)
SPY : 562.96 (-0.02%)
$DOWI : 41,621.18 (+0.04%)
DIA : 416.85 (-0.10%)
$IUXX : 19,508.68 (+0.39%)
QQQ : 473.49 (+0.38%)
ZNZ24 : 114-310 (-0.35%)
INCY : 65.42 (-1.52%)
AAPL : 221.48 (+2.16%)
WYNN : 79.01 (-1.24%)
LVS : 40.92 (-1.16%)
MGM : 37.05 (-0.43%)
Corbus Pharmaceuticals: Q1 Earnings Snapshot

Corbus Pharmaceuticals: Q1 Earnings Snapshot

CRBP : 49.63 (-2.50%)
Corbus Pharmaceuticals: Q4 Earnings Snapshot

Corbus Pharmaceuticals: Q4 Earnings Snapshot

CRBP : 49.63 (-2.50%)
Mira Pharmaceuticals Stock Is Soaring In November... Here's Why

Leveraging a favorable DEA classification for its synthetic analog of THC, Mira Pharmaceuticals could be on an expedited pathway toward commercialization to treat several unmet neurological m

MIRA : 1.2050 (-8.02%)
CARA : 0.2940 (+10.07%)
CRBP : 49.63 (-2.50%)
HRMY : 38.41 (-1.03%)
JAZZ : 109.68 (-1.68%)
Corbus Pharmaceuticals: Q3 Earnings Snapshot

Corbus Pharmaceuticals: Q3 Earnings Snapshot

CRBP : 49.63 (-2.50%)
Corbus Pharmaceuticals to Present Latest Pre-Clinical Data on its Anti-aVb8 Monoclonal Antibody (CRB-601) at the 2023 SITC Annual Meeting

/PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today announced that an...

CRBP : 49.63 (-2.50%)
Corbus Pharmaceuticals: Q2 Earnings Snapshot

Corbus Pharmaceuticals: Q2 Earnings Snapshot

CRBP : 49.63 (-2.50%)
Corbus Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

/PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a precision oncology company, today provided a corporate...

CRBP : 49.63 (-2.50%)

Business Summary

Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic...

See More

Key Turning Points

3rd Resistance Point 60.39
2nd Resistance Point 58.04
1st Resistance Point 54.47
Last Price 49.63
1st Support Level 48.55
2nd Support Level 46.19
3rd Support Level 42.62

See More

52-Week High 61.90
Last Price 49.63
Fibonacci 61.8% 39.41
Fibonacci 50% 32.47
Fibonacci 38.2% 25.52
52-Week Low 3.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar